1. Home
  2. Browse Decisions
  3. REGENERON PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS INC.
 

REGENERON PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS INC.

Nos. 2024-1402, 2024-1405.

REGENERON PHARMACEUTICALS, INC., Plaintiff-Appellant, v. MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC., Defendants-Cross-Appellants, AMGEN USA, INC., Defendant.

United States Court of Appeals, Federal Circuit.

April 12, 2024.

NOTE: This order is nonprecedential.

ORDER

Following this court's February 22, 2024 show cause order, the parties agree that the court lacks jurisdiction over both the appeal and cross-appeal from the district court's December 27, 2023 decision resolving fewer than all claims at issue. Under the circumstances, we agree and...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases